Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last --
Change Today 0.00 / 0.00%
Volume 0.0
4507 On Other Exchanges
Symbol
Exchange
4507 is not on other exchanges.
All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Isao Teshirogi Ph.D.

Chief Executive Officer, President and Representative Director, Shionogi & Co., Ltd.
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 2 different industries.

See Board Relationships
55--

Background*

Dr. Isao Teshirogi, Ph.D., has been the President and Chief Executive Officer of Shionogi & Co. Ltd. since April 1, 2008. Dr. Teshirogi served as the Executive General Manager of Pharmaceutical Research & Development Division at Shionogi & Co. Ltd., since 2006 and also served as its General Manager of Pharmaceutical Research & Development Division since 1999, General Manager of Secretary Office from January 1998 to October 2002 and General Manager of Corporate Planning ...

Read Full Background

Corporate Headquarters*

1-8, Doshomachi 3-chome
Osaka, -- 541-0045

Japan

Phone: 81 6 6202 2161
Fax: 81 6 6229 9596

Board Members Memberships*

2002-Present
Chief Executive Officer, President and Representative Director
2003-Present
Director

Education*

PhD
The University of Tokyo
BS
The University of Tokyo

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
4507:JP ¥4,640.00 JPY +30.00

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Michael W. Aguiar Chief Executive Officer, President and Director
Theravance Inc.
$557.2K
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.8M
Miles D. White Chairman, Chief Executive Officer and Chairman of Executive Committee
Abbott Laboratories
$2.0M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SHIONOGI & CO LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.